Search Results - "Cox, Nathan J."
-
1
Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia
Published in PloS one (24-06-2013)“…Protein kinases play key roles in oncogenic signaling and are a major focus in the development of targeted cancer therapies. Imatinib, a BCR-Abl tyrosine…”
Get full text
Journal Article -
2
A Novel Glycoproteomics Workflow Reveals Dynamic O-GlcNAcylation of COPγ1 as a Candidate Regulator of Protein Trafficking
Published in Frontiers in endocrinology (Lausanne) (15-10-2018)“…O-linked β-N-acetylglucosamine (O-GlcNAc) is an abundant and essential intracellular form of protein glycosylation in animals and plants. In humans,…”
Get full text
Journal Article -
3
Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteins
Published in Proceedings of the National Academy of Sciences - PNAS (05-06-2018)“…O-GlcNAc is an intracellular posttranslational modification that governs myriad cell biological processes and is dysregulated in human diseases. Despite this…”
Get full text
Journal Article -
4
Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking Pathway
Published in Biochemistry (Easton) (09-01-2018)“…The COPII coat complex, which mediates secretory cargo trafficking from the endoplasmic reticulum, is a key control point for subcellular protein targeting…”
Get full text
Journal Article -
5
Lyn regulates creatine uptake in an imatinib-resistant CML cell line
Published in Biochimica et biophysica acta. General subjects (01-04-2020)“…Imatinib mesylate (imatinib) is the first-line treatment for newly diagnosed chronic myeloid leukemia (CML) due to its remarkable hematologic and cytogenetic…”
Get full text
Journal Article -
6
Role of O‐GlcNAcylation in SEC24C function
Published in The FASEB journal (01-04-2020)“…Abstract only…”
Get full text
Journal Article -
7
Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia. e66755
Published in PloS one (01-06-2013)“…Protein kinases play key roles in oncogenic signaling and are a major focus in the development of targeted cancer therapies. Imatinib, a BCR-Abl tyrosine…”
Get full text
Journal Article